Guglielmo Borgia
Dipartimento di Medicina Pubblica e Sicurezza Sociale - Sezione di Malattie Infettive
Università di Napoli Federico II
Napoli
Italy
Name/email consistency: high
- Homocysteine levels and sustained virological response to pegylated-interferon alpha2b plus ribavirin therapy for chronic hepatitis C: a prospective study. Borgia, G., Gentile, I., Fortunato, G., Borrelli, F., Borelli, S., de Caterina, M., Di Taranto, M.D., Simone, M., Borgia, F., Viola, C., Reynaud, L., Cerini, R., Sacchetti, L. Liver Int. (2009)
- Treating chronic hepatitis B: today and tomorrow. Borgia, G., Gentile, I. Curr. Med. Chem. (2006)
- Hemolytic anemia during pegylated IFN-alpha2b plus ribavirin treatment for chronic hepatitis C: ribavirin is not always the culprit. Gentile, I., Viola, C., Reynaud, L., Borrelli, F., Cerini, R., Ciampi, R., Piazza, M., Borgia, G. J. Interferon Cytokine Res. (2005)
- Specific immunoglobulin against HCV: new perspectives. Borgia, G. IDrugs (2004)
- HepeX-C (XTL Biopharmaceuticals). Borgia, G. Curr. Opin. Investig. Drugs (2004)
- Pernicious anemia during IFN-alpha treatment for chronic hepatitis C. Borgia, G., Reynaud, L., Gentile, I., Borrelli, F., Cerini, R., Ciampi, R., Piazza, M. J. Interferon Cytokine Res. (2003)
- HIV and hepatitis C virus: facts and controversies. Borgia, G., Reynaud, L., Gentile, I., Piazza, M. Infection (2003)
- Myasthenia gravis during low-dose IFN-alpha therapy for chronic hepatitis C. Borgia, G., Reynaud, L., Gentile, I., Cerini, R., Ciampi, R., Dello Russo, M., Piazza, M. J. Interferon Cytokine Res. (2001)
- A case of paracoccidioidomycosis: experience with long-term therapy. Borgia, G., Reynaud, L., Cerini, R., Ciampi, R., Schioppa, O., Dello Russo, M., Gentile, I., Piazza, M. Infection (2000)